Astrazeneca PLC ORD SHS $0.25
Astrazeneca PLC ORD SHS $0.25/ GB0009895292 /
AZN
5/17/2024 5:51:06 PM
|
Chg.
-56.0000
|
Volume |
Bid6:30:00 PM |
Ask6:30:00 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
12,110.0000GBX
|
-0.46%
|
1.68 mill. Turnover(GBP): 165.03 mill. |
11,600.0000Bid Size: 100 |
12,470.0000Ask Size: 500 |
187.14 bill.GBP |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
3.84 USD |
81.13% |
EPS Diluted: |
- USD |
80.57% |
Revenues per Share: |
29.55 USD |
3.28% |
Book Value per Share: |
25.25 USD |
5.68% |
Cash Flow per Share: |
6.67 USD |
5.46% |
Dividend per Share: |
2.90 USD |
0.00% |
Total |
in mill. |
|
Revenues: |
45,811.00 USD |
3.29% |
Net Income: |
5,955.00 USD |
84.48% |
Operating Cash Flow: |
10,345.00 USD |
- |
Cash and Cash Equivalents: |
5,840.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
39.96 |
35.16 |
P/S Ratio: |
5.19 |
4.57 |
P/BV ratio: |
6.08 |
5.35 |
P/CF Ratio: |
23.00 |
20.23 |
PEG: |
0.49 |
0.43 |
Earnings Yield: |
2.50% |
2.84% |
Dividend Yield: |
1.89% |
2.15% |
Market Capitalization |
|
Market Capitalization: |
187.14 bill. GBP |
164.16 bill. GBP |
Free Float Market Cap.: |
137.74 bill. GBP |
- GBP |
Market Cap. / Employee: |
2.08 mill. GBP |
1.83 mill. GBP |
Shares Outstanding: |
1.55 bill. |
|
Profitability
Gross Profit Margin: |
81.95% |
EBIT Margin: |
17.88% |
Net Profit Margin: |
13.00% |
Return on Equity: |
15.21% |
Return on Assets: |
5.89% |
Financial Strength
Liquidity I / Cash Ratio: |
19.12% |
Liquidity II / Quick Ratio: |
58.82% |
Liquidity III / Current Ratio: |
82.03% |
Debt / Equity Ratio: |
158.33% |
Dynam. Debt / Equity Ratio: |
599.09% |
Efficiency
Employees: |
89,900 |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
509,577.31 USD |
Net Income / Employee: |
66,240.27 USD |
Total Assets / Employee: |
1,124,794.22 USD |
* Fiscal Year End: |
12/31/2023 |
Accounting Standard: |
IFRS |